The prognostic significance of p16(INK4a)/p14(ARF) and p15(INK4b) deletions in adult acute lymphoblastic leukemia

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1855-1861

  Faderl, Stefan ^a   Kantarjian, Hagop M ^a   Manshouri, Taghi ^a   Chan, Chin Yung ^a   Pierce, Sherry ^a   Hays, Kimberly J ^a   Cortes, Jorge ^a   Thomas, Deborah ^a   Estrov, Zeev ^a   Albitar, Maher ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; GENE PRODUCT; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN P53; UNCLASSIFIED DRUG; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN; PROTEIN P14ARF; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER SURVIVAL; CELL CYCLE; CHROMOSOME 9P; CLINICAL ARTICLE; GENE DELETION; HEPATOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FAMILY; SPLENOMEGALY; ACUTE LYMPHOCYTIC LEUKEMIA; AGE; CHROMOSOME 9; CHROMOSOME MAP; FEMALE; GENETIC MARKER; GENETICS; MALE; MIDDLE AGED; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE DELETION; GENES, P16; GENETIC MARKERS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PROGNOSIS; PROTEINS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 0032586978     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. 1 restriction point. Crit. Rev. Oncog., 7: 127-142, 1996.
2. ink4a gene and hematological malignancies. Leuk. Lymphoma, 22: 11-24, 1996.
3. Clurman, B. E., and Groudine, M. The CDKN2A tumor-suppressor locus: a tale of two proteins. N. Engl. J. Med., 338: 910-912, 1998.
4. ink4a gene inactivation in the development of human acute lymphoblastic leukemia. Haematologica, 80: 557-568, 1995.
5. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
6. Xiong, Y., Zhang, H., and Beach, D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev., 7: 1572-1583, 1993.
7. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
8. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
9. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayashi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y., Ueda, R., and Hirai, H. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 86: 1548-1556, 1995.
10. Siebert, R., Willers, C. P., Schramm, A., Fossa, A., Gana Dresen, I. M., Uppenkamp, M., Nowrousian, M. R., Seeber, S., and Opalka, B. Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines. Br. J. Haematol., 91: 350-354, 1995.
11. Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M., Tanaka, T., Mitani, K., Yazaki, Y., and Hirai, H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood, 84: 2431-2435, 1994.
12. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83: 993-1000, 1995.
13. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92: 713-723, 1998.
14. ink4b gene deletions in primary leukemias. Blood, 86: 311-315, 1995.
15. Kantarjian, H., O'Brien, S., Beran, M., Keating, M., Koller, C., Robertson, L., Andreeff, M., Murphy, S., and Freireich, E. Update of the hyper-CVAD program in newly diagnosed adult acute lymphocytic leukemia. Blood, 86: 173a, 1995.
16. Kantarjian, H. M., Walters, R. S., Keating, M. J., Smith, T. L., O'Brien, S., Estey, E. H., Huh, Y. O., Spinolo, J., Dicke, K., Barlogie, B., McCredie, K. B., and Freireich, E. J. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard-and high-risk acute lymphocytic leukemia. J. Clin. Oncol., 8: 994-1004, 1990.
17. Keating, M. J., Cork, A., Broach, Y., Smith, T., Walters, R. S., McCredie, K. B., Trujillo, J., and Freireich, E. J. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leuk. Res., 11: 119-133, 1987.
18. Snedecor, G. W., and Cochran, W. G. Statistical methods, 7th ed. Ames, IA: Iowa State University Press, 1980.
19. Kaplan, E. L., and Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457, 1958.
20. Faderl, S., Kantarjian, H. M., Talpaz, M., and Estrov, Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood, 92: 3995-4019, 1998.
21. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J. L., Bauters, F., Wattel, E., and Fenaux, P. p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85: 657-663, 1995.
22. Kowalczyk, J., and Sandberg, A. A. A possible subgroup of ALL with 9p-. Cancer Genet. Cytogenet., 9: 383-385, 1983.
23. Pollak, C., and Hagemeijer, A. Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia (Baltimore), 1: 541-548, 1987.
24. Laï, J. L., Fenaux, P., Pollet, J. P., Estienne, M. H., Savary, J. B., Huart, J. J., and Deminatti, M. Acute lymphocytic leukemias with 9p anomalies. Cancer Genet. Cytogenet., 33: 99-109, 1988.
25. Chilcote, R. R., Brown, E., and Rowley, J. D. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N. Engl. J. Med., 313: 286-291, 1985.
26. Takeuchi, S., Bartram, C. R., Seriu, T., Miller, C. W., Tobler, A., Janssen, J. W. G., Reiter, A., Ludwig, W-D., Zimmermann, M., Schwaller, J., Lee, E., Miyoshi, I., and Koeffler, H. P. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/ MTSI/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood, 86: 755-760, 1995.
27. Liu, Q., Neuhausen, S., McClure, M., Frye, C., Weaver-Feldhaus, J., Gruis, N. A., Eddington, K., Allalunis-Turner, M. J., Skolnick, M. H., Fujimura, F. K., and Kamb, A. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene, 11: 2455, 1995.
28. Olopade, O. I., Jenkins, R. B., Ransom, D. T., Malik, K., Pomykala, H., Nobori, T., Cowan, J. M., Rowley, J. D., and Diaz, M. O. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res., 52: 2523-2529, 1992.
29. Della Ragione, F., and Iolascon, A. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias. Leuk. Lymphoma, 25: 23-35, 1997.
30. Diccianni, M. B., Batova, A., Yu, J., Vu, T., Pullen, J., Amylon, M., Pollock, B. H., and Yu, A. L. Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions. Leuk. Res., 21: 549-558, 1997.
31. Guidal-Giroux, C., Gerard, B., Cavé, H., Duval, M., Rohrlich, P., Elion, J., Vilmer, E., and Grandchamp, B. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias. Br. J. Haematol., 92: 410-419, 1996.
32. INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9. Br. J. Haematol., 93: 632-636, 1996.
33. ink4 gene inactivation in childhood acute lymphoblastic leukaemia. Br. J. Haematol., 98: 147-150, 1997.
34. ink gene inactivation in acute lymphocytic leukemia. Blood, 85: 3431-3436, 1995.
35. Rubnitz, J. E., Behm, F. G., Pui, C. H., Evans, W. E., Relling, M. V., Raimondi, S. C., Harrison, P. L., Sandlund, J. T., Ribeiro, R. C., Grosveld, G., and Downing, J. R. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St. Jude Total Therapy Study XII. Leukemia (Baltimore), 11: 1201-1206, 1997.
36. INK4 gene inactivation in childhood acute lymphocytic leukemia. J. Clin. Oncol., 14: 1512-1520, 1996.
37. INK4A and p18, in childhood T cell lineage acute lymphoblastic leukemias. Leukemia (Baltimore), 10: 255-260, 1996.
38. Takeuchi, S., Koike, M., Seriu, T., Bartram, C. R., Slater, J., Park, S., Miyoshi, I., and Koeffler, H. P. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis. Leukemia (Baltimore), 11: 1636-1640, 1997.
39. Cayuela, J-M., Madani, A., Sanhes, L., Stern, M-H., and Sigaux, F. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood, 87: 2180-2186, 1996.
40. INK4B) display frequent homozygous deletions in primary cells form T-but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84: 4038-4044, 1994.
41. Aguiar, R. C. T., Sill, H., Goldman, J. M., and Cross, N. C. P. The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster. Leukemia (Baltimore), 11: 233-238, 1997.